Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States.
作者信息
Hammond Michael M, Cameron Natalie A, Ning Hongyan, Bah Imani, Beltrame Kaitlyn, Khan Sadiya S, Shah Nilay S
机构信息
Department of Medicine (Cardiology) Northwestern University Feinberg School of Medicine Chicago IL.
Department of Medicine (General Internal Medicine) Northwestern University Feinberg School of Medicine Chicago IL.
出版信息
J Am Heart Assoc. 2023 Apr 18;12(8):e029263. doi: 10.1161/JAHA.122.029263. Epub 2023 Apr 7.
Abstract
摘要
相似文献
1
Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States.美国边缘或中度风险成年人中他汀类药物的使用与动脉粥样硬化性心血管疾病一级预防的适用性
J Am Heart Assoc. 2023 Apr 18;12(8):e029263. doi: 10.1161/JAHA.122.029263. Epub 2023 Apr 7.
2
Trends in Statin Use for the Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults by Age, 1999-2020.
Mayo Clin Proc. 2024 Oct;99(10):1665-1668. doi: 10.1016/j.mayocp.2024.06.003. Epub 2024 Aug 9.
3
Trends in statin use for the primary prevention of atherosclerotic cardiovascular disease among US adults by demographic characteristics, 1999-2020.1999 年至 2020 年期间，根据人口统计学特征，美国成年人中用于动脉粥样硬化性心血管疾病一级预防的他汀类药物使用趋势。
Eur J Clin Pharmacol. 2024 Sep;80(9):1305-1315. doi: 10.1007/s00228-024-03699-1. Epub 2024 May 28.
4
Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.美国糖尿病患者使用他汀类药物后残余高甘油三酯血症与估计的动脉粥样硬化性心血管疾病风险：2007-2014 年全国健康和营养调查。
Diabetes Care. 2019 Dec;42(12):2307-2314. doi: 10.2337/dc19-0501. Epub 2019 Oct 1.
5
Atherosclerotic cardiovascular disease prevention: a comparison between the third adult treatment panel and the new 2013 Treatment of Blood Cholesterol Guidelines.动脉粥样硬化性心血管疾病的预防：第三次成人治疗小组与2013年新的《血液胆固醇治疗指南》之比较
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):778-9. doi: 10.1161/CIRCOUTCOMES.114.001139. Epub 2014 Aug 5.
6
Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.心脏结局预防评估试验对他汀类药物用于心血管疾病一级预防的适用性影响：来自美国国家健康与营养检查调查的见解
Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102.
7
A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.对 2013 年 ACC/AHA pooled cohort 风险评估工具用于动脉粥样硬化性心血管疾病的系统检查。
J Am Coll Cardiol. 2014 Sep 9;64(10):959-68. doi: 10.1016/j.jacc.2014.06.1186.
8
Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary Prevention.在一级预防中评估动脉粥样硬化性心血管疾病风险。
J Cardiopulm Rehabil Prev. 2022 Nov 1;42(6):397-403. doi: 10.1097/HCR.0000000000000746.
9
Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus.治疗老年糖尿病患者动脉粥样硬化性心血管疾病一级预防中的血脂异常
Clin Geriatr Med. 2020 Aug;36(3):457-476. doi: 10.1016/j.cger.2020.04.006. Epub 2020 Apr 17.
10
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.一种简单的基于疾病的方法，用于个性化调整老年人 ACC/AHA 推荐的他汀类药物分配：BioImage 研究。
J Am Coll Cardiol. 2016 Aug 30;68(9):881-91. doi: 10.1016/j.jacc.2016.05.084.
引用本文的文献
1
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据：美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
2
Primary Prevention for Intermediate Risk: The More Things Change, the More They Stay the Same.中度风险的一级预防：万变不离其宗。
JACC Adv. 2024 Mar 5;3(4):100884. doi: 10.1016/j.jacadv.2024.100884. eCollection 2024 Apr.
3
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据：美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
4
American Heart Association EPI|Lifestyle Scientific Sessions: 2022 Meeting Highlights.美国心脏协会流行病学与生活方式科学会议：2022年会议亮点
J Am Heart Assoc. 2023 Apr 18;12(8):e028695. doi: 10.1161/JAHA.122.028695. Epub 2023 Apr 12.
本文引用的文献
1
Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy.患者自述未使用一级预防他汀类药物治疗的原因。
J Clin Med. 2020 Oct 18;9(10):3337. doi: 10.3390/jcm9103337.
2
Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics.美国 1999-2018 年心脏病死亡率亚型的异质趋势：生命统计观察分析。
BMJ. 2020 Aug 13;370:m2688. doi: 10.1136/bmj.m2688.
3
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
4
Coronary Calcium Score and Cardiovascular Risk.冠状动脉钙评分与心血管风险。
J Am Coll Cardiol. 2018 Jul 24;72(4):434-447. doi: 10.1016/j.jacc.2018.05.027.
Zotero 插件